Marcus Washington
Family Medicine · Mason, OHNPI 1225026479
Payments from drug & device makers
Across 196 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$524
- AbbVie$389
- AstraZeneca$340
- Novo Nordisk$293
- Lilly USA, LLC$221
- Astellas Pharma US Inc$198
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,391100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 33 | $524 |
| AbbVie | 23 | $389 |
| AstraZeneca | 21 | $340 |
| Novo Nordisk | 22 | $293 |
| Lilly USA, LLC | 10 | $221 |
| Astellas Pharma US Inc | 9 | $198 |
| Exact Sciences | 11 | $188 |
| Amgen | 10 | $141 |
| Boehringer Ingelheim | 7 | $132 |
| Novartis | 7 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $121 |
| Kyowa Kirin, Inc. | 3 | $84 |
| Abbott | 3 | $75 |
| Bayer | 5 | $75 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Dexcom, Inc. | 3 | $57 |
| GSK | 3 | $45 |
| Inari Medical, Inc. | 1 | $44 |
| Amarin Pharma, Inc. | 3 | $43 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Verona Pharma, Inc. | 1 | $30 |
| Medtronic | 2 | $29 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Stryker | 1 | $23 |
| Edwards Lifesciences | 1 | $18 |
| Merck | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
How this compares
$3,391 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 111 | $147,811 |
| OzempicSemaglutide | 95 | $123,889 |
| EliquisApixaban | 95 | $96,627 |
| RybelsusSemaglutide | 52 | $88,212 |
| FarxigaDapagliflozin Propanediol | 44 | $53,590 |
| XareltoRivaroxaban | 65 | $52,906 |
| MounjaroTirzepatide | 25 | $37,959 |
| TrulicityDulaglutide | 28 | $36,359 |
| KerendiaFinerenone | 29 | $30,747 |
| Repatha SureclickEvolocumab | 34 | $30,302 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $25,038 |
| LinzessLinaclotide | 29 | $24,611 |
| EntrestoSacubitril/Valsartan | 18 | $22,351 |
| JanuviaSitagliptin Phosphate | 17 | $21,722 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 17 | $13,673 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $293 | $212,101147 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $132 | $161,484128 claims |
| PfizerEliquis | $524 | $96,62795 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $340 | $78,62883 claims |
| Lilly USA, LLCMounjaro, Trulicity | $221 | $74,31753 claims |
| Johnson & JohnsonXarelto | $13 | $52,90665 claims |
| BayerKerendia | $75 | $30,74729 claims |
| AbbVieLinzess, Synthroid | $389 | $27,47261 claims |
| NovartisEntresto | $123 | $22,35118 claims |
| MerckJanuvia | $15 | $21,72217 claims |
| GSKTrelegy Ellipta | $45 | $11,99217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Mason
- Albert WeisbrotMason$44K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.